Have a patient with type 2 diabetes? They may qualify for the Restore-1 clinical trial
HonorHealth Research Institute is enrolling eligible patients in the Restore-1 clinical trial, which is evaluating a new minimally invasive approach to improving blood sugar control in adults with type 2LEARN MORE

